The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis.
about
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Economic evaluations of adult male circumcision for prevention of heterosexual acquisition of HIV in men in sub-Saharan Africa: a systematic reviewHIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving ConceptsEarly and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysisPublic-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland comparedWhat is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South AfricaThe Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost-Benefit AnalysisThe macroeconomic consequences of renouncing to universal access to antiretroviral treatment for HIV in Africa: a micro-simulation model.Estimating the resources needed and savings anticipated from roll-out of adult male circumcision in Sub-Saharan Africa.Early severe morbidity and resource utilization in South African adults on antiretroviral therapy.Financing equitable access to antiretroviral treatment in South Africa.Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settingsFurther benefits by early start of HIV treatment in low income countries: survival estimates of early versus deferred antiretroviral therapy.The health related quality of life of people living with HIV/AIDS in sub-Saharan Africa - a literature review and focus group study.Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries.Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions.Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysisLong-term costs and health impact of continued global fund support for antiretroviral therapyIs there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries.HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions.A novel Markov model projecting costs and outcomes of providing antiretroviral therapy to public patients in private practices versus public clinics in South Africa.The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South AfricaEstimating the Impact and Cost of the WHO 2010 Recommendations for Antiretroviral Therapy.Cost-effectiveness of antiretroviral regimens in the World Health Organization's treatment guidelines: a South African analysis.Costs of providing care for HIV-infected adults in an urban HIV clinic in Soweto, South Africa.The economic burden of malaria on households and the health system in Enugu State southeast Nigeria.Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South AfricaCD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study.The Costs of Delivering Integrated HIV and Sexual Reproductive Health Services in Limited Resource Settings.Costs and process of in-patient tuberculosis management at a central academic hospital, Cape Town, South AfricaCost-Effectiveness of Initiating Antiretroviral Therapy at Different Points in TB Treatment in HIV-TB Coinfected Ambulatory Patients in South Africa.Field testing of a multicriteria decision analysis (MCDA) framework for coverage of a screening test for cervical cancer in South Africa.The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South AfricaThe cost-effectiveness of antiretroviral therapy for treating HIV disease in the CaribbeanRates and cost of hospitalization before and after initiation of antiretroviral therapy in urban and rural settings in South Africa.CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African WomenScaling up antiretroviral therapy in developing countries: what are the benefits and challenges?Antiretroviral therapy and early mortality in South AfricaCost estimates of HIV care and treatment with and without anti-retroviral therapy at Arba Minch Hospital in southern Ethiopia.
P2860
Q21034169-DFDB3B13-379D-49F0-92CC-114FD6E070B7Q21091142-3AD93EAE-4B03-4286-AA8E-A20FCE422E42Q22241321-C4A4A550-035C-46D8-94C5-D44F0FBCD3A1Q28472043-4CD5695E-6EB9-4CFB-92CD-3675C150F632Q28473120-46EDF416-C442-4908-AEEB-12BA60EDF324Q28485194-FEBB3868-AD31-4875-B72B-C3BB03F416D8Q28534733-87EC9BE1-A575-4DD6-AC84-818D9D5C3B4BQ28608172-E89747E8-E494-425C-8909-08B7752E0934Q30415562-B4A9EE80-3FD0-4747-B31F-53D1DE22DD8EQ33358016-9E8FB735-BD14-4D24-AF80-306A7C706E11Q33518021-525C4E5B-E90F-423B-A8C9-E9EE3D6E3BFAQ33623038-93FFDBFB-D12D-4ADC-B5DF-5344B1E69EB1Q33623045-2777A0B5-6A07-475F-9260-6217A8D315A0Q33718364-DF9B6970-FFE6-4F6A-8956-FA29212A4F33Q33816036-DA1509ED-A2FD-415B-B5FA-96241726FDF5Q33834900-EC8ADCF3-7CC0-4854-93CB-F2C7110F8197Q33907111-F08B8BEF-9FB4-476C-89B0-F33EC1579631Q33950833-82D1FA97-13DA-4F1C-8291-11312C654609Q33952153-E95E46FB-B195-45A7-A74A-6DC006F508CFQ34002707-3154D395-6895-42BF-80BA-C54C3FFE8448Q34339471-EA042EDC-C620-4599-802F-5F82CE963DFFQ34583843-E67E5775-4EF7-45EF-8C7C-BA1617B7821BQ34606231-4E6DC731-088B-4667-9CDD-CB18C038A670Q34735093-C31B59F9-2565-4EC9-BA60-7788CC8BE16EQ34768650-C9AD0444-720E-404E-ADBA-3347C8EF9C2BQ34831668-007BABA1-10AE-4C31-BCB0-C92628AA6F82Q35040885-AF6226DD-F043-4BBB-A605-4DC8F0FA0518Q35120904-E671F69C-75AC-4C78-A393-3285AE4E37F9Q35541572-92C5454C-29B2-449A-A152-28B348154CB9Q35561173-441E9266-3877-4040-88D5-1546FAED2200Q35718668-01C8299A-77CF-47AB-A309-78C42C5F4079Q35854983-4D94ED55-79EA-432E-8126-495A4D680EA4Q35898829-A7DF51F8-B390-48EA-9668-8ED8EACB3413Q35925982-C3A83659-6C5B-4E31-8532-589A1AF0E5E5Q36628346-10C3A286-6A25-4F7C-A10C-2A8F5833A57EQ36763727-1D0AC24D-0F3E-4E8D-AF5F-A8A419D09C72Q36966640-2C7ABD8E-7E10-4DA7-B33E-7A97CA90BF43Q37006157-7A7C440F-F5C6-42C6-9B86-C807147A2FCEQ37113094-649B0C71-9CE9-4578-AF3A-C1E97F346A37Q37166426-BDAD3FAB-38B8-4C99-B4D5-9B78F2078B04
P2860
The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The cost-effectiveness of anti ...... rica--a primary data analysis.
@ast
The cost-effectiveness of anti ...... rica--a primary data analysis.
@en
type
label
The cost-effectiveness of anti ...... rica--a primary data analysis.
@ast
The cost-effectiveness of anti ...... rica--a primary data analysis.
@en
prefLabel
The cost-effectiveness of anti ...... rica--a primary data analysis.
@ast
The cost-effectiveness of anti ...... rica--a primary data analysis.
@en
P2860
P921
P356
P1476
The cost-effectiveness of anti ...... rica--a primary data analysis.
@en
P2093
Susan M Cleary
P2860
P2888
P356
10.1186/1478-7547-4-20
P577
2006-12-06T00:00:00Z
P5875
P6179
1032326363